These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16022676)

  • 21. Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons.
    Baccei ML; Kocsis JD
    J Neurophysiol; 2000 Apr; 83(4):2227-38. PubMed ID: 10758131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards the discovery of novel T-type calcium channel blockers.
    Lory P; Chemin J
    Expert Opin Ther Targets; 2007 May; 11(5):717-22. PubMed ID: 17465728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathological changes of potential-activated calcium channels in sensory neurons].
    Kostiuk OP; Pinchenko VO; Kostiuk PH
    Fiziol Zh (1994); 2008; 54(3):81-91. PubMed ID: 18763584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New calcium channel blockers for the treatment of hypertension].
    Tamargo J
    Hipertens Riesgo Vasc; 2017; 34 Suppl 2():5-8. PubMed ID: 29908667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Involvement of N-type calcium channels in pain and antinociception].
    Wen L; Yang S; Zhou WX; Zhang YX; Zhou XW; Huang PT
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):23-8. PubMed ID: 15881339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of T-type calcium channels in epilepsy and pain.
    Nelson MT; Todorovic SM; Perez-Reyes E
    Curr Pharm Des; 2006; 12(18):2189-97. PubMed ID: 16787249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Block of voltage-gated calcium channels stimulates dopamine efflux in rat mesocorticolimbic system.
    Belardetti F; Ahn S; So K; Snutch TP; Phillips AG
    Neuropharmacology; 2009; 56(6-7):984-93. PubMed ID: 19371580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Voltage-Gated Sodium Channels in Pain Signaling.
    Bennett DL; Clark AJ; Huang J; Waxman SG; Dib-Hajj SD
    Physiol Rev; 2019 Apr; 99(2):1079-1151. PubMed ID: 30672368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium channels as therapeutic targets in neuropathic pain.
    Yaksh TL
    J Pain; 2006 Jan; 7(1 Suppl 1):S13-30. PubMed ID: 16426997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking calcium-channel isoforms to potential therapies.
    Belardetti F; Zamponi GW
    Curr Opin Investig Drugs; 2008 Jul; 9(7):707-15. PubMed ID: 18600576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties.
    Pudukulatham Z; Zhang FX; Gadotti VM; M'Dahoma S; Swami P; Tamboli Y; Zamponi GW
    Mol Pain; 2016; 12():. PubMed ID: 27053601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of subunits of voltage-gated calcium channels and actions of pregabalin on intrinsic primary afferent neurons in the guinea-pig ileum.
    Needham K; Bron R; Hunne B; Nguyen TV; Turner K; Nash M; Furness JB
    Neurogastroenterol Motil; 2010 Oct; 22(10):e301-8. PubMed ID: 20618837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathic pain: role of voltage-dependent calcium channels.
    Chaplan SR
    Reg Anesth Pain Med; 2000; 25(3):283-5. PubMed ID: 10834784
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract]   [Full Text] [Related]  

  • 37. Postsynaptic N-type or P/Q-type calcium channels mediate long-term potentiation by group I metabotropic glutamate receptors in the trigeminal oralis.
    Weon H; Kim TW; Youn DH
    Life Sci; 2017 Nov; 188():110-117. PubMed ID: 28882644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRP channels: potential drug target for neuropathic pain.
    Marwaha L; Bansal Y; Singh R; Saroj P; Bhandari R; Kuhad A
    Inflammopharmacology; 2016 Dec; 24(6):305-317. PubMed ID: 27757589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide leads new class of chronic pain drugs.
    Garber K
    Nat Biotechnol; 2005 Apr; 23(4):399. PubMed ID: 15815650
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of T-type calcium channels in peripheral and central pain processing.
    Todorovic SM; Jevtovic-Todorovic V
    CNS Neurol Disord Drug Targets; 2006 Dec; 5(6):639-53. PubMed ID: 17168748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.